H.Res. 928
Affirming support for most-favored-Nation drug pricing for United States patients.
Session
119th Congress Current
Status Pending
Referred to the House Committee on Energy and Commerce.Sponsors (2)
DDDebbie Dingell
Democrat · Primary
ECElijah Crane
Republican · Primary
Legislative Votes
No votes have been held on this legislation yet.